Ambeed.cn

首页 / / / 拓扑异构酶 / Amonafide

氨萘非特 /Amonafide 99%+

货号:A391656 同义名: AS1413;Benzisoquinolinedione Ambeed 开学季,买赠积分,赢豪礼

Amonafide produces protein-associated DNA-strand breaks through a topoisomerase II-mediated reaction, but does not produce topoisomerase I-mediated DNA cleavage.

Amonafide 化学结构 CAS号:69408-81-7
Amonafide 化学结构
CAS号:69408-81-7
Amonafide 3D分子结构
CAS号:69408-81-7
Amonafide 化学结构 CAS号:69408-81-7
Amonafide 3D分子结构 CAS号:69408-81-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Amonafide 纯度/质量文件 产品仅供科研

货号:A391656 标准纯度: 99%+
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell,2024. Ambeed. [ A125712 ]
Cancer Discov., 2024. Ambeed. [ A285925 ]
JMC, 2024. Ambeed. [ A288696 ]
JMC, 2024. Ambeed. [ A524399 , A633512 , A144280 , A174613 ]
EJNMMI Radiopharm. Chem., 2024, 9, 61. Ambeed. [ A1257961 , A622068 ]
更多 >
产品名称 Topo I Topo II Topo IV Topoisomerase 其他靶点 纯度
Ellagic acid 99%+
β-Lapachone 99%+
(s)-10-hydroxycamptothecin 99%+
Camptothecin ++

Topo I, IC50: 0.68 μM

98%
Betulinic acid ++

Eukaryotic topoisomerase I, IC50: 5 μM

99%+
Topotecan ++++

Topo I (DU-145 Luc cells), IC50: 2 nM

Topo I (MCF-7 Luc cells), IC50: 13 nM

99%+
Irinotecan HCl Trihydrate 98%
SN-38 98%
Levofloxacin hydrate 99%+
Dexrazoxane 99%+
Ofloxacin 98+%
Enoxacin 99%+
Flumequine +

Topo II, IC50: 15 μM

99%+
Levofloxacin 99%+
Etoposide 98%
Pefloxacin mesylate dihydrate 99+%
Marbofloxacin 99%+
Voreloxin HCl 98%
Mitoxantrone dihydrochloride PKC 99%+
Nalidixic acid 99%+
Doxorubicin 98%
Novobiocin sodium 98%+
Amonafide 99%+
Pirarubicin 98%+
Idarubicin HCl +++

Topo II (MCF-7 cells), IC50: 3.3 ng/mL

99%+
Genistein EGFR 98%
Teniposide 98%
Moxifloxacin 98%
Ciprofloxacin 99%+
Clinafloxacin 97%
Gatifloxacin 99%+
Daunorubicin HCl +++

DNA synthesis, Ki: 20 nM

98%
Epirubicin HCl 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Amonafide 生物活性

靶点
  • Topo II

描述 Topoisomerase II (topo II) is an enzyme essential for chromosome segregation and DNA supercoiling homeostasis[3]. Amonafide is a novel topoisomerase II (Topo II) inhibitor and DNA intercalator that induces apoptotic signaling by blocking the binding of Topo II to DNA[4]. In vitro, P-glycoprotein (Pgp)-mediated transport (efflux) of amonafide from myeloblasts obtained from patients with secondary acute myeloid leukemia (sAML) was significantly less than efflux of daunorubicin[4]. Amonafide produces protein-associated DNA cleavage, single-strand breaks (SSB) and DPC and DNA double-strand cleavage. Amonafide (400 nM-2.4 μM) reduces the colony-forming ability of the leukemic cell lines in a dose-dependent manner[5]. Amonafide has shown efficacy in patients with sAML, as well as in patients with poor prognostic characteristics such as older age and unfavorable cytogenetics, all associated with drug resistance (MDR). Improved antileukemic activity is observed when amonafide is given together with cytarabine, rather than as monotherapy, with a complete remission rate of ∼ 40% in a recent Phase II trial in sAML[4].

Amonafide 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00273884 Acute Myeloid Leukemia Phase 2 Completed - -
NCT00074100 Breast Cancer Phase 2 Completed - United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 <<
NCT00087854 Prostate Cancer Phase 1 Phase 2 Completed - United States, California ... 展开 >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Maryland Cancer Center at John Hopkins Baltimore, Maryland, United States, 21231 United States, Missouri Barnard Cancer Center St.Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, New York Herbert Irving Cancer Center New York, New York, United States, 10032-3789 United States, Ohio The Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 收起 <<

Amonafide 参考文献

[1]Hsiang YH, Jiang JB, et al. Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs. Mol Pharmacol. 1989 Sep;36(3):371-6.

[2]Andersson BS, Beran M, et al. In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC308847) in human leukemia. Cancer Res. 1987 Feb 15;47(4):1040-4.

[3]Lee JH, Wendorff TJ, Berger JM. Resveratrol: A novel type of topoisomerase II inhibitor. J Biol Chem. 2017 Dec 22;292(51):21011-21022. doi: 10.1074/jbc.M117.810580. Epub 2017 Oct 26. PMID: 29074616; PMCID: PMC5743075.

[4]Allen SL, Lundberg AS. Amonafide: a potential role in treating acute myeloid leukemia. Expert Opin Investig Drugs. 2011 Jul;20(7):995-1003. doi: 10.1517/13543784.2011.585756. Epub 2011 May 19. PMID: 21591994.

[5]Andersson BS, Beran M, Bakic M, Silberman LE, Newman RA, Zwelling LA. In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia. Cancer Res. 1987 Feb 15;47(4):1040-4. PMID: 3026621.

Amonafide 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.53mL

0.71mL

0.35mL

17.65mL

3.53mL

1.76mL

35.30mL

7.06mL

3.53mL

Amonafide 技术信息

CAS号69408-81-7
分子式C16H17N3O2
分子量 283.325
别名 AS1413;Benzisoquinolinedione;Xanafide;Quinamed;NSC 308847;NCI 308847;Nafidimide
运输蓝冰
存储条件

粉末 Keep in dark place,Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 40 mg/mL(141.18 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。